MARMARA MEDICAL JOURNAL, cilt.24, sa.1, ss.59-63, 2011 (ESCI)
Serum Paraoxonase-1(PON1) level, an anti-oxidant enzyme, decreases with diseases related to coronary heart diseases (CAH) such as diabetes, hypertension, hyperlipidemia and smoking. All clinical studies which were performed in patients with CAH have shown significant low levels and activity of PON1. These studies suggest that the PON1 level might be a marker for CAH, but more prospective and case-controlled studies are needed on this subject.